Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Lung Neoplasms 2Weight Loss 1Gastrointestinal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Cachexia 1Anorexia 1

Interventions

Surveys and Questionnaires 5Nivolumab 5pembrolizumab 3atezolizumab 3Radiosurgery 3pralsetinib 2pertuzumab 2cobimetinib 2cemiplimab 2amminedichloro(2-methylpyridine)platinum(II) 2alectinib 2Magnetic Resonance Spectroscopy 2Exercise 2Drug Therapy 2trastuzumab deruxtecan 1trametinib 1tepotinib 1talazoparib 1selpercatinib 1repotrectinib 1remune 1ponatinib 1pemigatinib 1pazopanib 1palbociclib 1osimertinib 1motexafin gadolinium 1montanide ISA 51 1itacitinib 1ipatasertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × Melatonin × Thoracic × Clear all
NCT00513357 2012-12-11

Melatonin Versus Placebo and the Effect on Appetite in Advanced Cancer Patients

M.D. Anderson Cancer Center

Phase 3 Completed
82 enrolled 7 charts
GastrointestinalThoracic

Anorexia, Cachexia, Gastrointestinal Neoplasms, Lung Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡